Retroviral insertional mutagenesis of a herpesvirus: A marek's disease virus mutant attenuated for oncogenicity but not for immunosuppression or in vivo replication

R. L. Witter, Deshan Li, Dan Jones, L. F. Lee, H. J. Kung

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Our earlier studies have shown that retrovirus insertion into herpesvirus is an efficient process that engenders recombinant herpesviruses with altered biological properties. The RM1 clone is derived from the JM strain of Marek's disease virus (MDV) through retrovirus insertional mutagenesis and contains sequences of reticuloendotheliosis virus inserted at the junction of the internal repeat and unique short regions of the genome. In previous studies, the RM1 clone appeared attenuated for oncogenicity but caused marked atrophy of the thymic lobes. The present studies represent a detailed analysis of the biological characteristics of the RM1 clone in order to better understand mechanisms of oncogenicity and gene function of MDV. RM1 was almost fully attenuated for oncogenicity but retained other in vivo properties of virulent viruses such as thymic and bursal atrophy, early immunosuppression, early cytolytic infection followed by efficient replication, and contact spread - all normally absent in attenuated strains. This suggests that, for serotype 1 MDV, oncogenicity is not tightly linked with immunodepression or viral replication and that these properties may be controlled by different genes or mechanisms. The mutation was stable through serial passage of the virus in chickens as determined by molecular analysis. None of the mutant viruses demonstrated expansion of the 132-bp repeat region of the genome, indicating that such expansion is not required for attenuation. Chickens vaccinated with RM1 clones were protected against challenge with virulent MDV, and levels of protection exceeded those of other attenuated serotype 1 vaccine viruses. Thus, attenuation by selective mutation may be an advantageous strategy for development of serotype 1 Marek's disease vaccines.

Original languageEnglish
Pages (from-to)407-421
Number of pages15
JournalAvian Diseases
Volume41
Issue number2
Publication statusPublished - Apr 1 1997
Externally publishedYes

Fingerprint

Marek Disease
insertional mutagenesis
Mardivirus
carcinogenicity
Insertional Mutagenesis
Herpesviridae
immunosuppression
Immunosuppression
Retroviridae
clones
Viruses
viruses
mutants
atrophy
Clone Cells
serotypes
Gallid herpesvirus 2
Reticuloendotheliosis virus
vaccines
chickens

Keywords

  • Attenuation
  • Insertional mutagenesis
  • Marek's disease
  • Mutant
  • Reticuloendotheliosis
  • Virulence
  • virus

ASJC Scopus subject areas

  • Food Animals
  • Animal Science and Zoology
  • Immunology and Microbiology(all)

Cite this

Retroviral insertional mutagenesis of a herpesvirus : A marek's disease virus mutant attenuated for oncogenicity but not for immunosuppression or in vivo replication. / Witter, R. L.; Li, Deshan; Jones, Dan; Lee, L. F.; Kung, H. J.

In: Avian Diseases, Vol. 41, No. 2, 01.04.1997, p. 407-421.

Research output: Contribution to journalArticle

@article{04b5bdffdc2a4fc98ecc20eb0106de7f,
title = "Retroviral insertional mutagenesis of a herpesvirus: A marek's disease virus mutant attenuated for oncogenicity but not for immunosuppression or in vivo replication",
abstract = "Our earlier studies have shown that retrovirus insertion into herpesvirus is an efficient process that engenders recombinant herpesviruses with altered biological properties. The RM1 clone is derived from the JM strain of Marek's disease virus (MDV) through retrovirus insertional mutagenesis and contains sequences of reticuloendotheliosis virus inserted at the junction of the internal repeat and unique short regions of the genome. In previous studies, the RM1 clone appeared attenuated for oncogenicity but caused marked atrophy of the thymic lobes. The present studies represent a detailed analysis of the biological characteristics of the RM1 clone in order to better understand mechanisms of oncogenicity and gene function of MDV. RM1 was almost fully attenuated for oncogenicity but retained other in vivo properties of virulent viruses such as thymic and bursal atrophy, early immunosuppression, early cytolytic infection followed by efficient replication, and contact spread - all normally absent in attenuated strains. This suggests that, for serotype 1 MDV, oncogenicity is not tightly linked with immunodepression or viral replication and that these properties may be controlled by different genes or mechanisms. The mutation was stable through serial passage of the virus in chickens as determined by molecular analysis. None of the mutant viruses demonstrated expansion of the 132-bp repeat region of the genome, indicating that such expansion is not required for attenuation. Chickens vaccinated with RM1 clones were protected against challenge with virulent MDV, and levels of protection exceeded those of other attenuated serotype 1 vaccine viruses. Thus, attenuation by selective mutation may be an advantageous strategy for development of serotype 1 Marek's disease vaccines.",
keywords = "Attenuation, Insertional mutagenesis, Marek's disease, Mutant, Reticuloendotheliosis, Virulence, virus",
author = "Witter, {R. L.} and Deshan Li and Dan Jones and Lee, {L. F.} and Kung, {H. J.}",
year = "1997",
month = "4",
day = "1",
language = "English",
volume = "41",
pages = "407--421",
journal = "Avian Diseases",
issn = "0005-2086",
publisher = "American Association of Avian Pathologists",
number = "2",

}

TY - JOUR

T1 - Retroviral insertional mutagenesis of a herpesvirus

T2 - A marek's disease virus mutant attenuated for oncogenicity but not for immunosuppression or in vivo replication

AU - Witter, R. L.

AU - Li, Deshan

AU - Jones, Dan

AU - Lee, L. F.

AU - Kung, H. J.

PY - 1997/4/1

Y1 - 1997/4/1

N2 - Our earlier studies have shown that retrovirus insertion into herpesvirus is an efficient process that engenders recombinant herpesviruses with altered biological properties. The RM1 clone is derived from the JM strain of Marek's disease virus (MDV) through retrovirus insertional mutagenesis and contains sequences of reticuloendotheliosis virus inserted at the junction of the internal repeat and unique short regions of the genome. In previous studies, the RM1 clone appeared attenuated for oncogenicity but caused marked atrophy of the thymic lobes. The present studies represent a detailed analysis of the biological characteristics of the RM1 clone in order to better understand mechanisms of oncogenicity and gene function of MDV. RM1 was almost fully attenuated for oncogenicity but retained other in vivo properties of virulent viruses such as thymic and bursal atrophy, early immunosuppression, early cytolytic infection followed by efficient replication, and contact spread - all normally absent in attenuated strains. This suggests that, for serotype 1 MDV, oncogenicity is not tightly linked with immunodepression or viral replication and that these properties may be controlled by different genes or mechanisms. The mutation was stable through serial passage of the virus in chickens as determined by molecular analysis. None of the mutant viruses demonstrated expansion of the 132-bp repeat region of the genome, indicating that such expansion is not required for attenuation. Chickens vaccinated with RM1 clones were protected against challenge with virulent MDV, and levels of protection exceeded those of other attenuated serotype 1 vaccine viruses. Thus, attenuation by selective mutation may be an advantageous strategy for development of serotype 1 Marek's disease vaccines.

AB - Our earlier studies have shown that retrovirus insertion into herpesvirus is an efficient process that engenders recombinant herpesviruses with altered biological properties. The RM1 clone is derived from the JM strain of Marek's disease virus (MDV) through retrovirus insertional mutagenesis and contains sequences of reticuloendotheliosis virus inserted at the junction of the internal repeat and unique short regions of the genome. In previous studies, the RM1 clone appeared attenuated for oncogenicity but caused marked atrophy of the thymic lobes. The present studies represent a detailed analysis of the biological characteristics of the RM1 clone in order to better understand mechanisms of oncogenicity and gene function of MDV. RM1 was almost fully attenuated for oncogenicity but retained other in vivo properties of virulent viruses such as thymic and bursal atrophy, early immunosuppression, early cytolytic infection followed by efficient replication, and contact spread - all normally absent in attenuated strains. This suggests that, for serotype 1 MDV, oncogenicity is not tightly linked with immunodepression or viral replication and that these properties may be controlled by different genes or mechanisms. The mutation was stable through serial passage of the virus in chickens as determined by molecular analysis. None of the mutant viruses demonstrated expansion of the 132-bp repeat region of the genome, indicating that such expansion is not required for attenuation. Chickens vaccinated with RM1 clones were protected against challenge with virulent MDV, and levels of protection exceeded those of other attenuated serotype 1 vaccine viruses. Thus, attenuation by selective mutation may be an advantageous strategy for development of serotype 1 Marek's disease vaccines.

KW - Attenuation

KW - Insertional mutagenesis

KW - Marek's disease

KW - Mutant

KW - Reticuloendotheliosis

KW - Virulence

KW - virus

UR - http://www.scopus.com/inward/record.url?scp=0031128028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031128028&partnerID=8YFLogxK

M3 - Article

C2 - 9201407

AN - SCOPUS:0031128028

VL - 41

SP - 407

EP - 421

JO - Avian Diseases

JF - Avian Diseases

SN - 0005-2086

IS - 2

ER -